Cortactin contributes to the tumorigenicity of colorectal cancer by promoting cell proliferation
Cited by 9
Related Papers
Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer
|Cell Death and Disease|2020|75
ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BB
|International Journal of Cancer|2019|60
MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF
|Cancer Cell International|2015|57